Gene · 7130
Papers2,523
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 2,523
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Potential of Mesenchymal Stem Cells in the Rejuvenation of the Aging Immune System. | Int J Mol Sci | 2021 | 34072224 | PubTator, text mining | PubMed |
| Fundamental and Advanced Therapies, Vaccine Development against SARS-CoV-2. | Pathogens | 2021 | 34064300 | PubTator, text mining | PubMed |
| Quantitative Mass Spectrometry-Based Proteomics for Biomarker Development in Ovarian Cancer. | Molecules | 2021 | 34063568 | PubTator, text mining | PubMed |
| Chronological Gene Expression of Human Gingival Fibroblasts with Low Reactive Level Laser (LLL) Irradiation. | J Clin Med | 2021 | 34062904 | PubTator, text mining | PubMed |
| 3D Bioprinting of Vascularized Tissues for in vitro and in vivo Applications. | Front Bioeng Biotechnol | 2021 | 34055761 | PubTator, text mining | PubMed |
| A novel therapeutic approach for inflammatory bowel disease by exosomes derived from human umbilical cord mesenchymal stem cells to repair intestinal barrier via TSG-6. | Stem Cell Res Ther | 2021 | 34051868 | PubTator, text mining | PubMed |
| Models that combine transcriptomic with spatial protein information exceed the predictive value for either single modality. | NPJ Precis Oncol | 2021 | 34050252 | PubTator, text mining | PubMed |
| Predicting the Key Genes Involved in Aortic Valve Calcification Through Integrated Bioinformatics Analysis. | Front Genet | 2021 | 34046056 | PubTator, text mining | PubMed |
| Harnessing the ECM Microenvironment to Ameliorate Mesenchymal Stromal Cell-Based Therapy in Chronic Lung Diseases. | Front Pharmacol | 2021 | 34040521 | PubTator, text mining | PubMed |
| NF-κB signalling pathways in nucleus pulposus cell function and intervertebral disc degeneration. | Cell Prolif | 2021 | 34028920 | PubTator, text mining | PubMed |
| Mesenchymal stem cell-inspired microgel scaffolds to control macrophage polarization. | Bioeng Transl Med | 2021 | 34027099 | PubTator, text mining | PubMed |
| Metabolic Reprogramming of GMP Grade Cord Tissue Derived Mesenchymal Stem Cells Enhances Their Suppressive Potential in GVHD. | Front Immunol | 2021 | 34017325 | PubTator, text mining | PubMed |
| Transcriptome responses in polar cod (Boreogadus saida) liver slice culture exposed to benzo[a]pyrene and ethynylestradiol: insights into anti-estrogenic effects. | Toxicol In Vitro | 2021 | 34015484 | PubTator, text mining | PubMed |
| Adult stem cells in endometrial regeneration: Molecular insights and clinical applications. | Mol Reprod Dev | 2021 | 34014590 | PubTator, text mining | PubMed |
| An Exploration of the Tumor Microenvironment Identified a Novel Five-Gene Model for Predicting Outcomes in Bladder Cancer. | Front Oncol | 2021 | 34012914 | PubTator, text mining | PubMed |
| Advances in mesenchymal stem cell therapy for immune and inflammatory diseases: Use of cell-free products and human pluripotent stem cell-derived mesenchymal stem cells. | Stem Cells Transl Med | 2021 | 34008922 | PubTator, text mining | PubMed |
| Application of regenerative medicine to salivary gland hypofunction. | Jpn Dent Sci Rev | 2021 | 33995711 | PubTator, text mining | PubMed |
| MSCs and Inflammatory Cells Crosstalk in Regenerative Medicine: Concerted Actions for Optimized Resolution Driven by Energy Metabolism. | Front Immunol | 2021 | 33995350 | PubTator, text mining | PubMed |
| Multi-omics approach identifies germline regulatory variants associated with hematopoietic malignancies in retriever dog breeds. | PLoS Genet | 2021 | 33983928 | PubTator, text mining | PubMed |
| The Current Dilemma and Breakthrough of Stem Cell Therapy in Ischemic Heart Disease. | Front Cell Dev Biol | 2021 | 33968924 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7130/papers?page=50